Contineum Therapeutics (CTNM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

13.500
+0.150+1.12%

Close Dec 20 16:00 ET

13.500
-0.0010.00%

Post 16:30 ET

348.00MMarket Cap-12.02P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Contineum Starts Patient Dosing in Positron Emission Tomography Trial
MT NewswiresDec 16 17:58 ET
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BenzingaDec 12 08:54 ET
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
BenzingaDec 12 05:41 ET
Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference
BusinesswireNov 25 08:05 ET
Express News | Contineum Therapeutics Inc - Expects $213.9 Mln Cash to Fund Operations Through 2027
ReutersNov 18 08:05 ET
Express News | Contineum Therapeutics Inc - Phase 1B Study for Pipe-791 to Begin in Q1 2025
ReutersNov 18 08:05 ET

Comments

Pinchie McPincher

Apr 19 03:23

$Contineum Therapeutics (CTNM.US)$what am i missing?

Jaguar8

Apr 4 22:56

$Contineum Therapeutics (CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.